Joining Jack
Joining Jack

Where Our Funds Go

We are particularly focused on translational research — research that takes potential therapeutics out of laboratories and into clinical trials.

Working closely with Duchenne UK, our scientific advisors, patient advisory board and trustees, we ensure that every grant we make is directed towards the most promising avenues for treatment. Our grants have generated breakthroughs that have transformed the therapeutic landscape for the Duchenne community.

Filter by Project Type:

Project NameResearch/Institution or CompanyProject StatusTotal Grant Award
Virtual HospitalsQueen Square Institute of Neurology, LondonOngoing£441,219
DMD Care TransitionLeeds Teaching HospitalOngoing£200,000
Smart Suit ProjectSMA UK & University of LiverpoolOngoing£150,000
DMD Care Phase 2Newcastle UniversityOngoing£150,000
DMD Hub Fellow / Clinical Trial SupportDr Anne-Marie Childs, Leeds Children's HospitalOngoing£35,000
Home-based video assessment of DMDAparitoOngoing£173,336
DMD Care NeuropsychiatristUniversity of GlasgowComplete£75,000
Antifibrotic / antiadipogenic drug — FibrogenesisNewcastle UniversityComplete£32,688
Hydrotherapy Clinical TrialDr De Geode, Royal Preston HospitalStarted£118,000
Immunology Grant Call AwardProf Kanneboyina Nagaraju, Binghamton State University of New YorkStarted£1,000
Biomarker TrialDuke UniversityStarted£20,000
Dream Chair DevelopmentWhizz KidzOngoing£50,000
DMD Care UKNewcastle UniversityOngoing£140,000
Immunology GrantUniversity of FloridaOngoing£185,000
Splint TrialNewcastle UniversityStarted£10,000
Stem CellsUniversity of MinnesotaStarted£140,000
Vitamin B3Leiden UniversityStarted£10,000
Tackling Fibrosis and Muscle RegenerationAgada BiosciencesStarted£25,000
Repurposing DrugsDr Olivier Dorchies, University of GenevaStarted£25,000
Testosterone Extension StudyProf Volker Straub, University of NewcastleStarted£10,000
Adult NMCCCDr Chiara Marini-Bettolo, University of NewcastleOngoing£10,000
Open Label Extension Study for TamoxifenDr Dirk Fischer, University Children's Hospital BaselPending£230,000
TaurineDr Peter Arthur, University of Western AustraliaOngoing£50,000
FibrosisDr Lee Borthwich, University of NewcastleOngoing£10,000
New Ways of Delivering Gene TherapyEVOX TherapeuticsOngoing£200,000
Understanding Heart Disease in DMDDr John Bourke, Freeman HospitalOngoing£67,000
Investigating Soy Products as TreatmentProf Steve Winder, University of SheffieldOngoing£30,500
Preclinical Study: Tamoxifen, L-Citrulline & MetforminDr Olivier Dorchies, University of GenevaOngoing£200,000
Use of Elastase Inhibitors to Treat DMDDr Addolorata Pisconti, University of LiverpoolOngoing£36,365
Duchenne Clinical Research NurseAlder Hey Children's Hospital, LiverpoolOngoing£32,106.50
F2 Neuromuscular Clinical Research DoctorAlder Hey Children's Hospital, LiverpoolComplete£30,513
ST4 Neuromuscular Clinical Research DoctorAlder Hey Children's Hospital, LiverpoolComplete£127,121
Tamoxifen Clinical TrialDr Dirk Fischer, University Children's Hospital BaselOngoing£194,996.99
Tamoxifen Project ManagerDr Dirk Fischer, University Children's Hospital BaselOngoing£97,000
TREAT-NMD DMD Co-Ordinator RoleUniversity of NewcastleOngoing£78,832.66
PhysiotherapistAlder Hey Children's Hospital, LiverpoolComplete£45,960
Duchenne Clinical Trial NurseRoyal Victoria Infirmary, NewcastleComplete£22,500
Clinical Research Lectureship / Senior LectureshipDr Guglieri, University of NewcastleOngoing£35,714.30
Preclinical Therapeutic Impact of CannabidiolDr Keith Foster, University of ReadingComplete£6,213.09
The Duchenne Forum: 8 Basic Research ProjectsMuscular Dystrophy CampaignComplete£55,346
Gene TherapySolid GT, Boston, USAComplete$1,666,666.66
VBP-15 Phase 1 Clinical TrialReveragen BioPharma Inc, USAComplete$400,000
DMD Heart Protection StudyDr Spinty, Alder HeyComplete£14,000
HT-100 Phase 1/2 Clinical TrialAkashi Therapeutics, USAComplete$100,000
Developing Biomarkers for Utrophin ModulatorsSummit Corporation, Oxford, UKComplete£100,000